|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 19 of 29 found articles
| Title: |
Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer |
| Author: |
Vergote, I. Finkler, N. del Campo, J. Lohr, A. Hunter, J. Matei, D. Kavanagh, J. Vermorken, J.B. Meng, L. Jones, M. Brown, G. Kaye, S. |
| Appeared in: |
European journal of cancer |
| Paging: | Volume 45 (2009) nr. 13 pages 9 p. |
| Year: |
2009 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 19 of 29 found articles
| << previous | next >> |